Hosted on MSN2d
GLP-1 Drug Shortage Is Over. Why Might These Drugs Soon Be Costlier and Harder to Access?
After years of shortages, the Food and Drug Administration (FDA) has now listed Novo Nordisk’s blockbuster diabetes and ...
Crain's Chicago Business2d
Behind burgeoning diabetes treatment, dueling UChicago and UIC profs
At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...
sun-courier2dOpinion
Dengler Domain: FTC
No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...
Endocrinology Advisor2d
GLP-1 Drug Shortages: How Do They Affect Patients With Diabetes?
Credit: Getty Images Experts weigh in on the ramifications of GLP-1 drug shortages and how they affect patients ... While ...
Insurancenewsnet.com3d
Pharmacy Benefit Manager math: Big chains paid $23.55 to fill a blood pressure Rx. Small drugstores paid $1.51
Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...
thelundreport5d
Justice Department antitrust division looking at health care conglomerates, pharmacy drug middlemen
The other, the Federal Trade Commission, is already conducting a major investigation of pharmacy benefit managers and is ...